2023年5期
刊物介紹
Hepatobiliary&Pancreatic Diseases International a journal published by First Affiliated Hospital,Zhejiang University School of Medicine,China. It p...Hepatobiliary&Pancreatic Diseases International a journal published by First Affiliated Hospital,Zhejiang University School of Medicine,China. It publishes peer-reviewed original papers,reviews and editorials econcerned with clinical practice and research in the fields of hepatobiliary and pancreatic cover the medical,surgical,radiological,pathological,biochemical,physiological and historical aspects of the subject areas under the headings Liver,Biliary,Pancreas,Transplantation,Research,Special Reports,Editorials,Review Articles,Brief Communications,Clinical Summary,Clinical Images and Case Reports. It also deals with the basic sciences and experimental work. The journal is abstracted adn indexed in SCI-E,IM/MEDLINE,EMBASE/EM,CA,Scopus,Science Direct,etc.更多簡介
Hepatobiliary & Pancreatic Diseases International
Special issue on gut-liver axis
- The role of the gut microbiome in chronic liver diseases: Present insights and future outlook
- Gut microbiome and nonalcoholic fatty liver disease
- The gut microbiome and intestinal failure-associated liver disease
- Contribution of gut microbiota to drug-induced liver injury
- In vivo mouse models to study bile acid synthesis and signaling
- Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure
ORIGINAL ARTICLES
- The effect of adjuvant transarterial chemoembolization for hepatocellular carcinoma after liver resection based on risk stratification
- ASARA,a prediction model based on Child-Pugh class in hepatocellular carcinoma patients undergoing transarterial chemoembolization
- Exosome is involved in liver graft protection after remote ischemia reperfusion conditioning
- Nonalcoholic fatty liver disease aggravates acute pancreatitis through bacterial translocation and cholesterol metabolic dysregulation in the liver and pancreas in mice
- Pathogen detection in patients with perihilar cholangiocarcinoma:Implications for targeted perioperative antibiotic therapy
- Targeting mitochondrial transcription factor A sensitizes pancreatic cancer cell to gemcitabine
NEW TECHNIQUES
- Combined hepatic segment color rendering technique improves the outcome of anatomical hepatectomy in patients with hepatocellular carcinoma
- Full laparoscopic anatomical liver segment VII resection with preferred Glissonean pedicle and dorsal hepatic approach
- A surgical technique using the gastroepiploic vein for portal inflow restoration in living donor liver transplantation in a patient with diffuse portomesenteric thrombosis
- Total three-dimensional laparoscopic radical resection for Bismuth type IV hilar cholangiocarcinoma
- Right hepatectomy with a cholangiojejunostomy and hepaticojejunostomy for unilobar Caroli’s syndrome